Cumberland Pharmaceuticals Inc.
CPIX
$4.49
-$0.27-5.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.19% | -348.15% | -481.30% | -110.83% | -12.73% |
| Total Depreciation and Amortization | 4.73% | 14.16% | 14.56% | 13.26% | 8.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -174.65% | 192.62% | 193.32% | 183.57% | 212.77% |
| Change in Net Operating Assets | -72.10% | -78.87% | -78.61% | -60.40% | -55.61% |
| Cash from Operations | -110.05% | -116.99% | -107.09% | -25.19% | -27.91% |
| Capital Expenditure | 76.36% | -42.73% | -28.28% | -18.14% | -175.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.21% | 149.36% | 285.43% | 281.54% | 342.88% |
| Cash from Investing | 154.63% | 134.27% | 126.16% | 103.42% | 99.23% |
| Total Debt Issued | 22.28% | 35.74% | 25.33% | -15.71% | -40.50% |
| Total Debt Repaid | -3.17% | -7.97% | 3.41% | 23.12% | 32.51% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 21.82% | 9.67% | -25.67% | -21.36% | 29.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 47.49% | 24.67% | 27.73% | 23.24% | -47.96% |
| Cash from Financing | 102.65% | 101.01% | 97.38% | 58.46% | -260.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 75.12% | -0.92% | -2,907.69% | 345.56% | 80.28% |